Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ENVB | US
-0.04
-1.77%
Healthcare
Biotechnology
30/06/2024
02/06/2026
2.22
2.33
2.35
2.20
Enveric Biosciences Inc. a biotechnology company engages in the development of small-molecule therapeutics for the treatment of anxiety depression and addiction disorders. Its lead program is EB-373 an active metabolite of psilocybin which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences Inc. is headquartered in Naples Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
57.0%1 month
82.8%3 months
231.9%6 months
219.7%-
23.09
0.73
-
-
0.29
1.76
-
-9.87M
19.80M
19.80M
-
-
-
-7.30
-206.10
1.86
2.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.55
Range1M
2.26
Range3M
6.17
Rel. volume
0.31
Price X volume
194.96K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| DOMH | DOMH | Biotechnology | 3.35 | 21.03M | 2.76% | n/a | 7.66% |
| Evaxion Biotech A/S | EVAX | Biotechnology | 3.75 | 20.92M | -3.85% | n/a | 837.11% |
| Dyadic International Inc | DYAI | Biotechnology | 0.6897 | 20.33M | -11.12% | n/a | 175.64% |
| InMed Pharmaceuticals Inc | INM | Biotechnology | 1.52 | 20.28M | -2.56% | n/a | 7.00% |
| Reviva Pharmaceuticals Holdings Inc. | RVPH | Biotechnology | 0.595 | 19.69M | -0.83% | n/a | 0.00% |
| Outlook Therapeutics Inc | OTLK | Biotechnology | 0.8136 | 19.25M | -3.49% | n/a | -39.11% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 3.11 | 18.96M | -4.01% | n/a | 0.00% |
| Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 0.4301 | 18.80M | -7.70% | n/a | 35.26% |
| DarT Bioscience Inc | DARE | Biotechnology | 2.14 | 18.29M | -2.28% | 0.12 | 218.34% |
| Enlivex Therapeutics Ltd | ENLV | Biotechnology | 0.8499 | 18.19M | -1.56% | n/a | 2.92% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.11 | 16.22M | -2.63% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4275 | 8.26M | -0.47% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.71 | 4.37M | 1.18% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.29 | - | Cheaper |
| Ent. to Revenue | 1.76 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.73 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 231.93 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 19.80M | - | Emerging |